» Articles » PMID: 38649888

The Influence of Maternal Prepregnancy Weight and Gestational Weight Gain on the Umbilical Cord Blood Metabolome: a Case-control Study

Overview
Publisher Biomed Central
Date 2024 Apr 22
PMID 38649888
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Maternal overweight/obesity and excessive gestational weight gain (GWG) are frequently reported to be risk factors for obesity and other metabolic disorders in offspring. Cord blood metabolites provide information on fetal nutritional and metabolic health and could provide an early window of detection of potential health issues among newborns. The aim of the study was to explore the impact of maternal prepregnancy overweight/obesity and excessive GWG on cord blood metabolic profiles.

Methods: A case control study including 33 pairs of mothers with prepregnancy overweight/obesity and their neonates, 30 pairs of mothers with excessive GWG and their neonates, and 32 control mother-neonate pairs. Untargeted metabolomic profiling of umbilical cord blood samples were performed using UHPLC‒MS/MS.

Results: Forty-six metabolites exhibited a significant increase and 60 metabolites exhibited a significant reduction in umbilical cord blood from overweight and obese mothers compared with mothers with normal body weight. Steroid hormone biosynthesis and neuroactive ligand‒receptor interactions were the two top-ranking pathways enriched with these metabolites (P = 0.01 and 0.03, respectively). Compared with mothers with normal GWG, in mothers with excessive GWG, the levels of 63 metabolites were increased and those of 46 metabolites were decreased in umbilical cord blood. Biosynthesis of unsaturated fatty acids was the most altered pathway enriched with these metabolites (P < 0.01).

Conclusions: Prepregnancy overweight and obesity affected the fetal steroid hormone biosynthesis pathway, while excessive GWG affected fetal fatty acid metabolism. This emphasizes the importance of preconception weight loss and maintaining an appropriate GWG, which are beneficial for the long-term metabolic health of offspring.

Citing Articles

Impact of Maternal Pre-Pregnancy Underweight on Cord Blood Metabolome: An Analysis of the Population-Based Survey of Neonates in Pomerania (SNiP).

Lichtwald A, Ittermann T, Friedrich N, Lange A, Winter T, Kolbe C Int J Mol Sci. 2024; 25(14).

PMID: 39062795 PMC: 11276627. DOI: 10.3390/ijms25147552.

References
1.
Tuersunjiang N, Odhiambo J, Long N, Shasa D, Nathanielsz P, Ford S . Diet reduction to requirements in obese/overfed ewes from early gestation prevents glucose/insulin dysregulation and returns fetal adiposity and organ development to control levels. Am J Physiol Endocrinol Metab. 2013; 305(7):E868-78. PMC: 3798706. DOI: 10.1152/ajpendo.00117.2013. View

2.
Cesar H, Pisani L . Fatty-acid-mediated hypothalamic inflammation and epigenetic programming. J Nutr Biochem. 2016; 42:1-6. DOI: 10.1016/j.jnutbio.2016.08.008. View

3.
Stirrat L, Just G, Homer N, Andrew R, Norman J, Reynolds R . Glucocorticoids are lower at delivery in maternal, but not cord blood of obese pregnancies. Sci Rep. 2017; 7(1):10263. PMC: 5579291. DOI: 10.1038/s41598-017-10266-5. View

4.
Johnson C, Ivanisevic J, Siuzdak G . Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol. 2016; 17(7):451-9. PMC: 5729912. DOI: 10.1038/nrm.2016.25. View

5.
Christie S, ORielly R, Li H, Wittert G, Page A . High fat diet induced obesity alters endocannabinoid and ghrelin mediated regulation of components of the endocannabinoid system in nodose ganglia. Peptides. 2020; 131:170371. DOI: 10.1016/j.peptides.2020.170371. View